年龄和饮食对小鼠甘油三代谢的影响
Kathryn M Spitler1, Shwetha K Shetty1, Brandon S J Davies1
1Department of Biochemistry and Molecular Biology, Fraternal Order of Eagles Diabetes Research Center, and Obesity Research and Education Initiative, University of Iowa, Iowa City, IA.
Journal of lipid research
|November 20, 2024
概括
年龄和饮食对三甘代谢的影响在小鼠和人类中不同. 虽然老鼠随着年龄的增长表现出更好的脂肪耐受性,但omega-3脂肪酸饮食增强了胰岛素敏感性和心脏的甘油三酸吸收.
科学领域:
- 代谢性疾病研究研究.
- 营养科学 营养科学
- 老龄化研究研究.
背景情况:
- 年龄和饮食显著影响人类的甘油三代谢和代谢健康.
- 血甘油三水平通常随着人类的年龄增长而上升.
- 饮食中的脂肪,特别是和脂肪和欧米茄-3脂肪酸,会对甘油三水平产生不同的影响.
研究的目的:
- 研究年龄和饮食对小鼠甘油三代谢的长期影响.
- 为了比较与年龄相关的三糖化物代谢在小鼠和人类之间的变化.
主要方法:
- 雄性和雌性C57Bl/6小鼠被食低脂肪,西方或富含omega-3的饮食长达两年.
- 测量的关键参数包括生存率,身体组成,血甘油三水平,基洛米克朗清除率以及口服脂肪,葡萄糖和胰岛素耐受性.
- 还评估了三甘在特定组织 (如心脏) 中的吸收.
主要成果:
- 与人类趋势相反,小鼠的血甘油三水平没有随着年龄的增长而增加,无论饮食如何.
- 在老鼠中,口服脂肪耐受性随着年龄的增长而有所改善,而胆米克朗清除率保持不变.
- 与其他组相比,食用omega-3饮食的小鼠表现出增加的瘦肉量,较低的胰岛素水平和显著更高的心脏甘油三摄入量.
- 西方饮食消费与降低生存率有关.
结论:
- 在C57Bl/6小鼠中,与年龄相关的甘油三代谢变化与在人类中观察到的不同.
- 老鼠表现出与年龄相关的脂肪吸收下降,但保持血甘油三清除,导致更好的脂肪耐受性.
- 长期的富含omega-3脂肪酸的饮食会促进胰岛素敏感性和心脏三糖的吸收,尽管确切的机制需要进一步阐明.
相关概念视频
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...


